EVIDENCE LIBRARY
Spinal-Cord-Stimulation Cohort’s Benzodiazepine Covariate Did Not Establish Treatment Failure
A surgical-device cohort examined medication purchases alongside stimulation outcomes. Benzodiazepine exposure was not a demonstrated independent cause of explantation.
A surgical-device cohort examined medication purchases alongside stimulation outcomes. Benzodiazepine exposure was not a demonstrated independent cause of explantation.
The analysis
The study followed 203 patients with failed-back-surgery syndrome and used national purchase records for several drug classes. Outcomes included trial success, later explantation, and opioid reduction.
The prominent associations concerned gabapentinoid use and higher preimplant opioid exposure. Benzodiazepines were included among covariates, with imprecise nonsignificant comparisons in the reported table.
What the record can answer
Purchase information is useful but does not establish administration, indication, or dose effects on each outcome. Patients receiving different medicines may differ in pain, anxiety, disability, and treatment history.
Explantation also is not identical to every measure of symptom response. The paper cannot establish that a benzodiazepine caused stimulation failure or that a nonsignificant association proves no relevant effect. A case review should retain the reason for treatment, actual exposure, device course, and patient-centered outcomes.
Source paper
Original analysis of the supplied journal article, identified as PMC8632751.